IP Library Patent Application 13729544
Patent Application
App. No. 13/729,544

Method for Treating Metabolic Syndrome and Diabetes Using Quercetin and Bauhinia fortificata Extract

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/729,544
Abstract

This invention relates to a method of treating metabolic syndrome and diabetes using a composition containing quercetin, vitamin B 3 , vitamin C, and a Bauhinia fortificata extract.

Claims (20)

1 . A composition for treating metabolic syndrome or diabetes, the composition comprising quercetin, vitamin B3, vitamin C, and a Bauhinia fortificata extract, wherein a weight ratio between quercetin, vitamin B3, vitamin C, and the Bauhinia fortificata extract is 1:0.02-1.5:0.2-2.5:0.5-3.

2 . The composition of claim 1 , wherein the weight ratio is 1:0.04:1:1.

3 . The composition of claim 1 , wherein the weight ratio is 1:0.04:0.5:0.5.

4 . The composition of claim 1 , wherein the weight ratio is 1:0.5:0.5:1.

5 . The composition of claim 1 , wherein the composition is in dry form.

6 . The composition of claim 1 , wherein the composition is in liquid form.

7 . The composition of claim 1 , wherein the composition is a food product.

8 . The composition of claim 1 , wherein the composition is a dietary supplement or a pharmaceutical formulation.

9 . The composition of claim 8 , wherein the composition is a tablet, a capsule, a soft chew, or a gel.

10 . The composition of claim 1 , further comprising folic acid, genistein, genistin, curcumin, resveratrol, luteolin, epigallocatechin gallate (EGCG), coenzyme Q10, eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA).

11 . The composition of claim 10 , wherein the composition includes luteolin or epigallocatechin gallate (EGCG).

12 . A method for treating diabetes, the method comprising administering to a subject in need thereof an effective amount of a composition that includes quercetin, vitamin B3, vitamin C, and a Bauhinia fortificata extract, wherein a weight ratio between quercetin, vitamin B3, vitamin C, and the Bauhinia fortificata extract is 1:0.02-1.5:0.2-2.5:0.5-3.

13 . The method of claim 12 , wherein the composition further includes folic acid, genistein, genistin, curcumin, resveratrol, isoquercetin, luteolin, epigallocatechin gallate (EGCG), coenzyme Q10, eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA).

14 . A method for improving the efficacy of a diabetes medication, comprising administering to a subject taking a diabetes medication an effective amount of a composition that includes quercetin, vitamin B3, vitamin C, and a Bauhinia fortificata extract, wherein a weight ratio between quercetin, vitamin B3, vitamin C, and the Bauhinia fortificata extract is 1:0.02-1.5:0.2-2.5:0.5-3.

15 . The method of claim 14 , wherein the diabetes medication is insulin, a sulfonylurea, a meglitinide, a biguanide, a thiazolidinedione, an alpha-glucosidase inhibitor, a DPP-4 inhibitor, or an adjunct therapy.

16 . The method of claim 15 , wherein the diabetes medication is metformin and the quercetin is isoquercetin.

17 . The method of claim 14 , wherein the composition further includes folic acid, genistein, genistin, curcumin, resveratrol, isoquercetin, luteolin, epigallocatechin gallate (EGCG), coenzyme Q10, eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA).

18 . A method for treating metabolic syndrome, the method comprising administering to a subject in need thereof an effective amount of a composition that includes quercetin, vitamin B3, vitamin C, and a Bauhinia fortificata extract, wherein a weight ratio between quercetin, vitamin B3, vitamin C, and the Bauhinia fortificata extract is 1:0.02-1.5:0.2-2.5:0.5-3.

19 . The method of claim 18 , wherein the composition further includes folic acid, genistein, genistin, curcumin, resveratrol, isoquercetin, luteolin, epigallocatechin gallate (EGCG), coenzyme Q10, eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA).

20 . A method for treating diabetes, the method comprising administering to a subject in need thereof an effective amount of a composition that includes quercetin, vitamin B3, vitamin C, a Bauhinia fortificata extract, luteolin, and epigallocatechin gallate (EGCG) as the only active ingredients, and a weight ratio between quercetin, vitamin B3, vitamin C, and the Bauhinia fortificata extract is 1:0.02-1.5:0.2-2.5:0.5-3.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: QUERCEGEN PHARMA A.G.
To: LINES, THOMAS CHRISTIAN
Reel/Frame 052151/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: LINES, THOMAS CHRISTIAN
To: QUERCIS PHARMA A.G.
Reel/Frame 052153/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2020
From: LINES, THOMAS; QUERCEGEN PHARMA LLC; QUERCEGEN PHARMA LLP; QUERCEGEN TECHNOLOGIES; QUERCEGEN PHARMACEUTICALS, LLC; QUERCEGEN HOLDINGS, LLC; NEW SUN NUTRITION, LLC; THE FRS COMPANY
To: QUERCEGEN PHARMA, AG.
Reel/Frame 052110/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2013
From: LINES, THOMAS CHRISTIAN
To: QUERCEGEN PHARMACEUTICALS LLC
Reel/Frame 029867/0293 →